Tue, November 16, 2010
Mon, November 15, 2010
Fri, November 12, 2010
Thu, November 11, 2010
Wed, November 10, 2010
Tue, November 9, 2010
Mon, November 8, 2010
Sun, November 7, 2010
Sat, November 6, 2010
Fri, November 5, 2010
Thu, November 4, 2010

InVivo Therapeutics to Present at Lazard Capital Markets Annual Healthcare Conference


  Copy link into your clipboard //business-finance.news-articles.net/content/201 .. apital-markets-annual-healthcare-conference.html
  Print publication without navigation Published in Business and Finance on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that Frank Reynolds, CEO of InVivo, will be presenting at the Lazard Capital Markets Annual Healthcare Conference on Tuesday, November 16, 2010 at 3:40 P.M. Eastern Time at the St. Regis Hotel in New York City.

A live webcast of this presentation will be available on the investor relations page of the InVivo Therapeutics website at [ www.invivotherapeutics.com ]. A replay of the webcast will be archived on the website for two weeks.

About InVivo Therapeutics

InVivo Therapeutics Holdings Corp. is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of proprietary technology co-invented by Robert Langer, ScD, Professor at Massachusetts Institute of Technology, and Joseph P. Vacanti, MD, who is affiliated with Massachusetts General Hospital in Boston.


Publication Contributing Sources